FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), wherein
where R1 and R2 are identical or different and each independently represents a C1-4alkyl group; X is -OH or a group represented by formula (II) where R6 is a hydrogen atom; Ra and Rb are identical or different and each independently represents a hydrogen atom, carboxylC1-8an alkyl group or a carboxyl group; ring A is an arene, C3-6 heterocycle containing 1 to 4 heteroatoms selected from the group consisting of O and N, C3-8cycloalkane ring or C3-8cycloalkene ring, where said C3-6 heterocycle, said C3-8cycloalkane ring and said C3-8cycloalkene ring can be further substituted with an oxo group, in addition to Ya and Yb; Ya is a hydrogen atom, a halogen atom, a carboxyl group, a hydroxyl group, C1-3alkoxycarbonyl group, carboxylC1-3alkyl group or a sulpho group; Yb is a hydrogen atom, a halogen atom, a carboxyl group, a hydroxyl group, C1-3alkoxycarbonyl group, carboxylC1-3alkyl group or C1-3alkoxy group; p is 0 or 1; q is 1; and R7 represents hydrogen atom or halogen atom; or a pharmaceutically acceptable salt thereof.
EFFECT: invention is used as hyperglycemic inhibitors having a serine protease inhibitory action.
23 cl, 14 tbl, 9 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
N-HYDROXYFORMAMIDE DERIVATIVE AND MEDICATION CONTAINING IT | 2011 |
|
RU2569851C2 |
METALLO-β-LACTAMASE INHIBITORS | 2006 |
|
RU2462450C2 |
TRIAZOLOPYRIDINE COMPOUND AND ACTION THEREOF AS PROLYL HYDROXYLASE INHIBITOR AND ERYTHROPOIETIN PRODUCTION INDUCER | 2010 |
|
RU2538963C2 |
NEW PIPERIDINE COMPOUND OR SALT THEREOF | 2013 |
|
RU2581834C1 |
DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
4-OXOQUINOLINE COMPOUND AND ITS USING AS HIV INTEGRASE INHIBITOR | 2003 |
|
RU2275361C2 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
BICYCLIC PYRROLE DERIVATIVES | 2005 |
|
RU2382786C2 |
THIOPHENE COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS | 2006 |
|
RU2424238C2 |
Authors
Dates
2018-08-20—Published
2013-06-14—Filed